Hospira Oxaliplatin Injection 100 mg/20 mL vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

oxaliplatin, Quantity: 5 mg/mL

제공처:

Hospira Australia Pty Ltd

INN (국제 이름):

Oxaliplatin

약제 형태:

Injection, intravenous infusion

구성:

Excipient Ingredients: tartaric acid; sodium hydroxide; water for injections

관리 경로:

Intravenous

패키지 단위:

1 x 20 mL

수업:

Medicine Listed (Export Only)

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumour * Treatment of advanced colorectal cancer.

제품 요약:

Visual Identification: Clear colourless solution practically free of particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Licence status A

승인 날짜:

2013-03-25